Search

Your search keyword '"Labetalol adverse effects"' showing total 36 results

Search Constraints

Start Over You searched for: Descriptor "Labetalol adverse effects" Remove constraint Descriptor: "Labetalol adverse effects" Journal british journal of clinical pharmacology Remove constraint Journal: british journal of clinical pharmacology
36 results on '"Labetalol adverse effects"'

Search Results

1. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.

2. Interaction of indomethacin and sulindac with labetalol.

3. A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.

4. Comparison of labetalol with other anti-hypertensive drugs.

5. Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.

6. Review of long-term treatment with labetalol.

7. Use of labetalol in the treatment of severe hypertension during pregnancy.

8. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.

9. A study of labetalol in patients of European, West Indian and West African origin.

10. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.

11. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

12. Intravenous labetalol in hypertensive patients given by fast and slow injection.

13. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.

14. Treatment of severe hypertension by repeated bolus injections of labetalol.

15. Labetalol in the treatment of patients with hypertension and renal function impairment.

16. Experience with labetalol in hypertension.

17. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.

18. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

19. Labetalol in long-term treatment of hypertension.

20. Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.

21. Labetalol in general practice: a review.

22. Double-blind trial of labetalol.

23. A multicentre open trial of labetalol in New Zealand.

24. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.

25. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

26. Comparison of labetalol and propranolol in hypertension.

27. Closing remarks: current status of labetalol.

28. A long-term study of labetalol in general practice.

29. Labetalol in essential hypertension.

30. Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol.

31. Controlled comparison of labetalol and propranolol in the management of severe hypertension.

32. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.

33. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

34. Labetalol in resistant hypertension.

35. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.

36. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.

Catalog

Books, media, physical & digital resources